SCHEMBL26416682

SCHEMBL26416682

c1ccc(-c2ccc(N(c3ccccc3)c3ccc4c(c3)oc3cccc(-c5ccc(-c6nc(-c7ccccc7)nc(-c7ccccc7)n6)cc5)c34)cc2)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.33
NR1H4 Q96RI1 1/20 0.33
ALDH1A1 P00352 7/20 0.32
MEN1 O00255 4/20 0.32
KMT2A Q03164 4/20 0.32
HPGD P15428 4/20 0.32
BACE1 P56817 1/20 0.32
KDM4E B2RXH2 7/20 0.32
TDP1 Q9NUW8 3/20 0.32
RECQL P46063 2/20 0.32
THRB P10828 1/20 0.32
BLM P54132 1/20 0.32
POLB P06746 1/20 0.32
ABCG2 Q9UNQ0 1/20 0.32
CRHR1 P34998 1/20 0.32
SMN1; SMN2 Q16637 4/20 0.32
TSHR P16473 2/20 0.32
LMNA P02545 2/20 0.32
GLA P06280 2/20 0.32
L3MBTL1 Q9Y468 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24746383 0.98 HCRTR1 (0.33) MAPTNR1H4ALDH1A1MEN1KMT2A
SCHEMBL26420579 0.97 HCRTR1 (0.32) MAPTNR1H4ALDH1A1MEN1KMT2A
SCHEMBL26420566 0.97 GPR55 (0.32) MAPTNR1H4ALDH1A1MEN1KMT2A
SCHEMBL24255661 0.96 MAPT (0.33) MAPTNR1H4ALDH1A1MEN1KMT2A
SCHEMBL26778841 0.96 ALDH1A1 (0.33) MAPTNR1H4ALDH1A1MEN1KMT2A
SCHEMBL26778850 0.95 HCRTR1 (0.35) MAPTNR1H4ALDH1A1MEN1KMT2A
SCHEMBL24255591 0.95 MAPT (0.33) MAPTNR1H4ALDH1A1MEN1KMT2A
SCHEMBL24255592 0.95 MAPT (0.33) MAPTNR1H4ALDH1A1MEN1KMT2A
SCHEMBL26420463 0.95 MAPT (0.33) MAPTNR1H4ALDH1A1MEN1KMT2A
SCHEMBL26420590 0.95 MAPT (0.33) MAPTNR1H4ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230128360-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230128360-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DEVICE CRY1, ORC3, ODC1 MAPT 950/4885NR1H4 1772/4885ALDH1A1 27/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.